JP2004523567A5 - - Google Patents

Download PDF

Info

Publication number
JP2004523567A5
JP2004523567A5 JP2002569776A JP2002569776A JP2004523567A5 JP 2004523567 A5 JP2004523567 A5 JP 2004523567A5 JP 2002569776 A JP2002569776 A JP 2002569776A JP 2002569776 A JP2002569776 A JP 2002569776A JP 2004523567 A5 JP2004523567 A5 JP 2004523567A5
Authority
JP
Japan
Prior art keywords
compound
malic acid
pharmaceutically acceptable
pharmaceutical composition
free base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002569776A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004523567A (ja
JP4078206B2 (ja
Filing date
Publication date
Priority claimed from GBGB0103046.9A external-priority patent/GB0103046D0/en
Application filed filed Critical
Publication of JP2004523567A publication Critical patent/JP2004523567A/ja
Publication of JP2004523567A5 publication Critical patent/JP2004523567A5/ja
Application granted granted Critical
Publication of JP4078206B2 publication Critical patent/JP4078206B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002569776A 2001-02-07 2002-02-06 テルビナフィンのリンゴ酸付加塩 Expired - Fee Related JP4078206B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0103046.9A GB0103046D0 (en) 2001-02-07 2001-02-07 Organic Compounds
PCT/EP2002/001249 WO2002070455A1 (en) 2001-02-07 2002-02-06 Malic acid addition salts of terbinafine

Publications (3)

Publication Number Publication Date
JP2004523567A JP2004523567A (ja) 2004-08-05
JP2004523567A5 true JP2004523567A5 (OSRAM) 2005-12-22
JP4078206B2 JP4078206B2 (ja) 2008-04-23

Family

ID=9908301

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002569776A Expired - Fee Related JP4078206B2 (ja) 2001-02-07 2002-02-06 テルビナフィンのリンゴ酸付加塩

Country Status (27)

Country Link
US (2) US20040147603A1 (OSRAM)
EP (1) EP1370513B1 (OSRAM)
JP (1) JP4078206B2 (OSRAM)
KR (2) KR20080041756A (OSRAM)
CN (1) CN1216034C (OSRAM)
AT (1) ATE294154T1 (OSRAM)
AU (1) AU2002238534C1 (OSRAM)
BR (1) BR0207077A (OSRAM)
CA (1) CA2437592A1 (OSRAM)
CZ (1) CZ20032132A3 (OSRAM)
DE (1) DE60203890T2 (OSRAM)
DK (1) DK1370513T3 (OSRAM)
EC (1) ECSP034713A (OSRAM)
ES (1) ES2240698T3 (OSRAM)
GB (1) GB0103046D0 (OSRAM)
HU (1) HUP0303174A3 (OSRAM)
IL (2) IL157241A0 (OSRAM)
MX (1) MXPA03007072A (OSRAM)
NO (1) NO20033473L (OSRAM)
NZ (1) NZ527300A (OSRAM)
PL (1) PL204812B1 (OSRAM)
PT (1) PT1370513E (OSRAM)
RU (1) RU2289570C2 (OSRAM)
SI (1) SI1370513T1 (OSRAM)
SK (1) SK9992003A3 (OSRAM)
WO (1) WO2002070455A1 (OSRAM)
ZA (1) ZA200306029B (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050209339A1 (en) * 2002-07-02 2005-09-22 Ercem Atillasoy Methods for the treatment of sinusitis
GB0503942D0 (en) * 2005-02-25 2005-04-06 Novartis Ag Purification process
RU2286144C2 (ru) * 2004-12-02 2006-10-27 Государственное научное учреждение Институт экспериментальной ветеринарии Сибири и Дальнего Востока Сибирского отделения Россельхозакадемии (ГНУ ИЭВСиДВ СО РАСХН) Способ лечения микроспории кошек
WO2007104474A1 (en) * 2006-03-10 2007-09-20 Novartis Ag Antifungal compositions comprising (1) a salt of terbinafine with malic acid and (2) malic acid
EP2043604A2 (en) 2006-06-14 2009-04-08 Dr. Reddy's Laboratories Ltd. Topical compositions
RU2350343C1 (ru) * 2007-08-13 2009-03-27 Государственное научное учреждение Институт экспериментальной ветеринарии Сибири и Дальнего Востока Сибирского отделения Россельхозакадемии (ГНУ ИЭВС и ДВ СО Россельхозакадемии) Способ лечения микроспории кошек
KR101733773B1 (ko) 2009-01-16 2017-05-10 엑셀리시스, 인코포레이티드 N-(4-{〔6,7-비스(메틸옥시)퀴놀린-4-일〕옥시}페닐)-n'-(4-플루오로페닐)사이클로프로판-1,1-디카르복사미드의 말산염 및 그 결정형
CN106106449A (zh) * 2016-06-21 2016-11-16 广西中烟工业有限责任公司 特比萘芬制剂及其在提高烟叶角鲨烯含量中的应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507755A (en) * 1967-10-17 1970-04-21 Bayer Ag Process for the purification of acrylonitrile by distillation with side stream withdrawal and decantation
US4276125A (en) 1979-02-02 1981-06-30 Asahi Kasei Kogyo Kabushiki Kaisha Process for purification of crude olefinically unsaturated nitrile and condenser useful for same process
US4269667A (en) 1979-08-02 1981-05-26 Standard Oil Company Acrylonitrile purification by extractive distillation
ATE10272T1 (de) * 1979-08-22 1984-11-15 Sandoz Ag Propenylamine, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und ihre verwendung als arzneimittel.
KR850001603B1 (ko) 1980-12-03 1985-10-24 아사히 가세이 고오교오 가부시기가이샤 불포화 니트릴의 제조법
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
NZ227042A (en) * 1987-11-27 1991-05-28 Banyu Pharma Co Ltd Substituted alkylamine derivatives and pharmaceutical compositions
US6005001A (en) 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
HU219480B (hu) 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
US5461068A (en) * 1993-09-29 1995-10-24 Corwood Laboratories, Inc. Imidazole derivative tincture and method of manufacture
DE4400770C1 (de) * 1994-01-13 1995-02-02 Lohmann Therapie Syst Lts Wirkstoffhaltiges Pflaster zur Abgabe von Estradiol mit mindestens einem Penetrationsverstärker, Verfahren zu seiner Herstellung und seine Verwendung
NZ280065A (en) * 1995-09-20 1998-04-27 Apotex Inc Preparation of n-alkyl-n-(1-naphthylmethyl)alk-2-en-4-ynylamine derivatives
CA2285368A1 (en) * 1997-03-31 1998-10-08 Johnson & Johnson Consumer Companies Inc. Solvent system for enhanced penetration of pharmaceutical compounds
WO1999049895A2 (en) 1998-03-31 1999-10-07 Johnson And Johnson Consumer Companies, Inc. Method for increasing the permeability of horny human tissue
US6231875B1 (en) 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
AU758679B2 (en) * 1998-07-24 2003-03-27 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
JP2000053681A (ja) 1998-08-10 2000-02-22 Sankyo Co Ltd 三環性複素環化合物を含有する抗菌剤
ATE245624T1 (de) 1999-10-22 2003-08-15 Richter Gedeon Vegyeszet Verfahren zur herstellung substituierter allylamin derivative und deren salze
GB0014448D0 (en) 2000-06-13 2000-08-09 Novartis Ag Organic compounds
JP4899139B2 (ja) 2000-08-10 2012-03-21 株式会社ポーラファルマ 抗真菌医薬組成物
JP4803511B2 (ja) 2000-08-25 2011-10-26 株式会社ポーラファルマ 抗真菌医薬組成物
JP2002068975A (ja) 2000-08-25 2002-03-08 Pola Chem Ind Inc 抗真菌医薬組成物

Similar Documents

Publication Publication Date Title
JP2005518413A5 (OSRAM)
JP2006515626A5 (OSRAM)
JP2006526031A5 (OSRAM)
JP2006514012A5 (OSRAM)
JP2007522220A5 (OSRAM)
JP2009502743A5 (OSRAM)
JP2009535462A5 (OSRAM)
EP2422788A3 (en) Benzodiazepines and compositions and uses thereof
JP2004534850A5 (OSRAM)
JP2006503588A5 (OSRAM)
JP2003503454A5 (OSRAM)
JP2008513510A5 (OSRAM)
EP1604989A8 (en) DPP-IV inhibitors
EP1659111A3 (en) Piperidine derivatives useful as ccr5 antagonists
JP2002332234A5 (OSRAM)
JP2009538336A5 (OSRAM)
JP2007537301A5 (OSRAM)
JP2006518752A5 (OSRAM)
JP2004523567A5 (OSRAM)
JP2010507589A5 (ja) Cb1受容体モジュレーターとしての1,5−ジフェニル−3−ピリジニルアミノ−1,5−ジヒドロピロリジン−2−オン
JP2008517059A5 (OSRAM)
JP2008546809A5 (OSRAM)
JP2004529205A5 (OSRAM)
ATE464043T1 (de) Pharmazeutische zusammensetzung enthaltend l- arginin
JP2008515980A5 (OSRAM)